Skip to content
Compazine Stops Tumor Cells From Hiding episode artwork

Mar 17, 2020 1 min

Compazine Stops Tumor Cells From Hiding

from Dr. Howard Smith OnCall Hosted by Howard G. Smith MD, AM

Vidcast: https://youtu.be/y45ok4Y3Lig The good ole nausea drug, Compazine or prochlorperazine, prevents tumor cells from hiding surface receptors that immunotherapy drugs require for the kill. Oncologists at Australia’s University of Queenland studied this receptor hiding process called endocytosis in both human cells and a mouse model. Studying human squamous cell carcinoma cells, they observed less endocytosis and more antibody binding sites in cells from patients responding better to cetuximab, an anticancer antibody to skin growth factor. The endocytosis inhibitor Compazine demonstrably helped cancer immunotherapy in mice. The drug turbocharged tumor cell killing by both the anti-tumor antibody cetuximab and the check point inhibitor avelumab. Compazine may well be an effective antidote to immunotherapy failures. Hui Yi Chew, Priscila O. De Lima, Jazmina L. Gonzalez Cruz, etal. Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell, 2020; 180 (5): 895 DOI: 10.1016/j.cell.2020.02.019 #endocytosis #immunotherapy #compazine #prochlorperazine

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Compazine Stops Tumor Cells From Hiding

0:00 1:07

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Dr. Howard Smith OnCall?

This episode is 1 minute long.

When was this Dr. Howard Smith OnCall episode published?

This episode was published on March 17, 2020.

Can I download this Dr. Howard Smith OnCall episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.